AU3976099A - Compositions and methods involving regulation of mammalian circadian rhythms - Google Patents

Compositions and methods involving regulation of mammalian circadian rhythms

Info

Publication number
AU3976099A
AU3976099A AU39760/99A AU3976099A AU3976099A AU 3976099 A AU3976099 A AU 3976099A AU 39760/99 A AU39760/99 A AU 39760/99A AU 3976099 A AU3976099 A AU 3976099A AU 3976099 A AU3976099 A AU 3976099A
Authority
AU
Australia
Prior art keywords
compositions
methods involving
circadian rhythms
mammalian circadian
involving regulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU39760/99A
Other languages
English (en)
Inventor
Nicholas Gekakis
David Staknis
Charles J. Weitz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Harvard College
Original Assignee
Harvard College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harvard College filed Critical Harvard College
Publication of AU3976099A publication Critical patent/AU3976099A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU39760/99A 1998-05-07 1999-05-06 Compositions and methods involving regulation of mammalian circadian rhythms Abandoned AU3976099A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8461098P 1998-05-07 1998-05-07
US60084610 1998-05-07
PCT/US1999/010072 WO1999057137A1 (fr) 1998-05-07 1999-05-06 Compositions et procedes impliquant une regulation des rythmes circadiens de mammiferes

Publications (1)

Publication Number Publication Date
AU3976099A true AU3976099A (en) 1999-11-23

Family

ID=22186081

Family Applications (1)

Application Number Title Priority Date Filing Date
AU39760/99A Abandoned AU3976099A (en) 1998-05-07 1999-05-06 Compositions and methods involving regulation of mammalian circadian rhythms

Country Status (2)

Country Link
AU (1) AU3976099A (fr)
WO (1) WO1999057137A1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0890578A3 (fr) * 1997-07-08 2001-09-26 Smithkline Beecham Plc Polynucleotides codant le géne d'horloge humaine et leur utilisation
US6555328B1 (en) * 1999-06-08 2003-04-29 Aventis Pharmaceuticals Inc. Screening methods for altering circadian rhythms and for human casein kinase I δ and/or ε phosphorylation of human clock proteins, period 1, -2 and -3
DE60042280D1 (de) * 1999-11-18 2009-07-09 Mitsubishi Tanabe Pharma Corp Transgene säugetiere mit einem period 1 promotor, der rhythmische expression verleiht
US7468178B2 (en) 1999-11-24 2008-12-23 Neurosciences Research Foundation, Inc. Methods for identifying compounds that modulate vigilance states
EP1234059A2 (fr) * 1999-11-24 2002-08-28 Neurosciences Research Foundation Inc. Acides nucleiques en rapport avec la vigilance et methodes connexes diagnostiques, therapeutiques et de criblage
US6730287B1 (en) 2000-04-03 2004-05-04 Neurosciences Research Foundation Inc. Methods for identifying compounds that modulate vigilance states
EP1248107A3 (fr) * 2001-03-22 2002-10-16 IPF Pharmaceuticals GmbH Procédé et appareil de criblage à résolution temporelle
WO2003086462A1 (fr) * 2002-03-29 2003-10-23 Celestar Lexico-Sciences,Inc. Inhibiteurs de phosphorylation c-jun
US8193155B2 (en) 2009-02-09 2012-06-05 Elc Management, Llc Method and compositions for treating skin
US8703161B2 (en) 2007-08-13 2014-04-22 Elc Management, Llc Skin repair compositions comprising circadian gene activators and a synergistic combination of Sirt1 gene activators
FR2940970B1 (fr) * 2009-01-09 2012-05-04 Isp Investments Inc Nouveaux peptides anti-age et composition cosmetique et/ou pharmaceutique les contenant
FR2940972B1 (fr) * 2009-01-09 2015-07-31 Isp Investments Inc Nouveaux peptides anti-age et composition cosmetique et/ou pharmaceutique les contenant
FR2940969B1 (fr) * 2009-01-09 2012-05-04 Isp Investments Inc Nouveaux peptides anti-age et composition cosmetique et/ou pharmaceutique les contenant
FR2940971B1 (fr) * 2009-01-09 2011-02-18 Isp Investments Inc Nouveaux peptides anti-age et composition cosmetique et/ou pharmaceutique les contenant
US10383815B2 (en) 2012-09-14 2019-08-20 Elc Management Llc Method and compositions for improving selective catabolysis in cells of keratin surfaces

Also Published As

Publication number Publication date
WO1999057137A9 (fr) 2001-12-20
WO1999057137A1 (fr) 1999-11-11

Similar Documents

Publication Publication Date Title
AU1803601A (en) Methods and compositions for the introduction of molecules into cells
AU3225897A (en) Regulation of gene expression
AU2212299A (en) Compositions and methods for the treatment of tumor
AU3976099A (en) Compositions and methods involving regulation of mammalian circadian rhythms
AU6134698A (en) Fluoroelastomer compositions and methods of producing same
AU2022999A (en) Methods and apparatus for perfusion of isolated tissue structure
AU1511399A (en) Method and composition of an oral preparation of itraconazole
AU5699799A (en) Makeup compositions and methods of making same
PL330235A1 (en) Derivatives of spiropiperidine and their application as therapeutic agents
AU1751795A (en) Liposome compositions and methods for the treatment of atherosclerosis
AU2051600A (en) Compositions and methods of modulating cholesterol metabolism
EP1119365A4 (fr) Compositions et procedes permettant d'utiliser les cellules tumorales
AU3068699A (en) Skin equivalent and methods of forming and using same
IL136110A0 (en) Methods and compositions for the treatment of psoriasis
AU9016898A (en) Methods and compositions for treatment of restenosis
AUPN816196A0 (en) Regulation of eukaryotic gene expression
AU4018897A (en) Novel 3,4-diaryloxazolone derivatives, methods of preparation and therapeutic uses thereof
AU2821295A (en) Compositions and methods for the treatment of tumors
AU8588898A (en) Composition and process for the treatment of epidermal traumas such as decubitusulcers
AU1390199A (en) Compositions and methods for inhibiting the activity of certain genes
AU5923998A (en) 2-benzoylamino-3-phenylpropenamide derivatives and methods of using the same
AU2289495A (en) Dihydropyrimidine dehydrogenase compositions and methods of use
AU4468093A (en) Composition and methods for the generation of bone
AU5026600A (en) Methods of regulating the condition of mammalian keratinous tissue
AU6412599A (en) Oxybutynin formulations and methods of use

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase